Brian N. Swanson - Concepedia

Author

Brian N. Swanson

Also Known As

B SWANSON, B. N. SWANSON, B. N. Swanson, B. Swanson, B.N. Swanson, BRIAN N. SWANSON, Brian N Swanson, Brian N. Swanson, Brian Swanson, Brooke E Swanson

Publications

7.9K

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson University Sanofi (United States)Regeneron (United States)United States Military Academy Sanofi (France)

About

Brian N. Swanson is an author at Thomas Jefferson University specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	785
2	Health Sciences	4	4	75
3	Allergy	2	2	60
4	Natural Sciences	1	1	375
5	Social Sciences	1	1	20

Brian N. Swanson

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma Mario Castro, Jonathan Corren, Ian Pavord, New England Journal of Medicine	2018	1.8K
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, New England Journal of Medicine	2018	1.1K
Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents Karnail S. Atwal, Brian N. Swanson, Steven E. Unger, Journal of Medicinal Chemistry	1991	782
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis Claus Bachert, Leda Mannent, Robert M. Naclerio, JAMA	2016	769
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, Journal of Allergy and Clinical Immunology	2018	647
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis Ikuo Hirano, Evan S. Dellon, Jennifer D. Hamilton, Gastroenterology	2019	434
Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines Karnail S. Atwal, George C. Rovnyak, S. David Kimball, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic Chemistry3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic Acid EstersAltmetric Attention ScoreOrganic Chemistry	1990	375
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans Gissette Reyes‐Soffer, Marianna Pavlyha, Colleen Ngai, Circulation	2016	230
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases Jennifer D. Hamilton, Sivan Harel, Brian N. Swanson, Clinical & Experimental Allergy	2021	174
Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis Karin Jonstam, Brian N. Swanson, Leda Mannent, Allergy	2018	166

Page 1